{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:46:17Z","timestamp":1790765177341,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.thromres.2008.03.008","type":"journal-article","created":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T09:34:52Z","timestamp":1208943292000},"page":"100-107","source":"Crossref","is-referenced-by-count":12,"title":["Monitoring aspirin treatment in patients with thrombocytosis: Comparison of the platelet function analyzer (PFA)-100 with optical aggregometry"],"prefix":"10.1016","volume":"123","author":[{"given":"Argirios E.","family":"Tsantes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Mantzios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Giannopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Tsirigotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos","family":"Bonovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdoxia","family":"Rapti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissavet","family":"Mygiaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafirios","family":"Kartasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos M.","family":"Sitaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dervenoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthi","family":"Travlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2008.03.008_bib1","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y","article-title":"Essential thrombocythemia: clinical evolutionary and biologic data","volume":"58","author":"Bellucci","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2008.03.008_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/asheducation-2005.1.409","article-title":"Platelets and thrombosis in myeloproliferative diseases","author":"Harrison","year":"2005","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.thromres.2008.03.008_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2008.03.008_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s002770050345","article-title":"Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decreased of large von Willebrand factor multimers in plasma","volume":"75","author":"van Genderen","year":"1997","journal-title":"Am Hematol"},{"key":"10.1016\/j.thromres.2008.03.008_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-0032-1313612","article-title":"Description of an in vitro platelet function analyzer \u2013 PFA-100","volume":"21","author":"Kundu","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.03.008_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1067\/mlc.2001.117406","article-title":"Platelet function analyzer \u2013 PFA-100: a tool to quantify congenital or acquired platelet dysfunction","volume":"138","author":"Jilma","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.thromres.2008.03.008_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0037-1614626","article-title":"Evaluation of PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease","volume":"82","author":"Cattaneo","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.03.008_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0049-3848(99)00102-4","article-title":"Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion","volume":"96","author":"Cattaneo","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2008.03.008_bib9","first-page":"614","article-title":"Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation","volume":"84","author":"Escolar","year":"1999","journal-title":"Hematologica"},{"key":"10.1016\/j.thromres.2008.03.008_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100","volume":"83","author":"Homoncik","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.03.008_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05511.x","article-title":"The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults","volume":"130","author":"Harrison","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2008.03.008_bib12","first-page":"29","article-title":"Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment","volume":"34","author":"Murphy","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.thromres.2008.03.008_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1582-4934.2001.tb00140.x","article-title":"Abnormalities of platelet aggregation in chronic myeloproliferative disorders","volume":"5","author":"Avram","year":"2001","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.thromres.2008.03.008_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2008.03.008_bib15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1309\/K58EWK4HPD51U3BE","article-title":"Platelet dysfunction in primary thrombocythemia using the Platelet Function Analyzer, PFA-100","volume":"123","author":"Cesar","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thromres.2008.03.008_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1076029606291428","article-title":"Determination of von Willebrand factor activity: Evaluation of the Haemosil\u2122 assay in comparison with established procedures","volume":"12","author":"Sucker","year":"2006","journal-title":"Clin Appl Thromb\/Hemost"},{"key":"10.1016\/j.thromres.2008.03.008_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2141.1997.d01-2127.x","article-title":"Prevention and treatment of thrombotic complications in ET: efficacy and safety of aspirin","volume":"97","author":"van Genderen","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2008.03.008_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bcmd.2005.12.031","article-title":"Thrombotic complications in essential thrombocythemia (ET): Clinical facts and biochemical riddles","volume":"36","author":"Petrides","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.thromres.2008.03.008_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/(SICI)1096-8652(199804)57:4<277::AID-AJH2>3.0.CO;2-R","article-title":"Aspirin increases the bleeding side effects in essential thrombocythemia independent of the cyclooxygenase pathway: role of the lipooxygenase pathway","volume":"57","author":"Cortelazzo","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2008.03.008_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ajcp\/91.6.647","article-title":"Platelet function and structure in myeloproliferative disease, myelodysplastic syndrome, and secondary thrombocytosis","volume":"91","author":"Raman","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thromres.2008.03.008_bib21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/01.STR.0000162719.11058.bd","article-title":"Screening for aspirin responsiveness after transient ischemic attack and stroke. Comparison of 2 point-of-care platelet function tests with optical aggregometry","volume":"36","author":"Harrison","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2008.03.008_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(02)02956-4","article-title":"Effect of a single dose of aspirin on platelets in humans with multiple risk factors for coronary artery disease","volume":"462","author":"Malinin","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.thromres.2008.03.008_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09537100400020161","article-title":"Can platelet aggregometry be standardized?","volume":"16","author":"Breddin","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2008.03.008_bib24","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1046\/j.1538-7836.2003.00354.x","article-title":"Aspirin resistance: a revival of platelet aggregation tests?","volume":"1","author":"De Gaetano","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.03.008_bib25","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1046\/j.1538-7836.2003.00284.x","article-title":"Aspirin resistance: definition, mechanisms and clinical reads-outs","volume":"1","author":"Patrono","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.03.008_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/09537109909169175","article-title":"Can the Platelet Function Analyzer (PFA)\u2013100 test substitute for the template bleeding time in routine clinical practice?","volume":"10","author":"Francis","year":"1999","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2008.03.008_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2125.1997.00639.x","article-title":"A comparison of the effects of aspirin on bleeding time measured using the PFA-100, in healthy volunteers","volume":"44","author":"Marshall","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.thromres.2008.03.008_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2141.2003.04727.x","article-title":"In vitro aspirin resistance detected by PSA-100TM closure time: pivotal role of plasma von Willebrand factor","volume":"124","author":"Chakroun","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2008.03.008_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00277-002-0462-7","article-title":"Excessive prolongation of the Ivy bleeding time after aspirin in essential thrombocythemia is also demonstrable in vitro in the high shear stress system PFA-100","volume":"81","author":"Troost","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.thromres.2008.03.008_bib30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2516.2001.00486.x","article-title":"Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations","volume":"7","author":"Favaloro","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2008.03.008_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2257.1999.00254.x","article-title":"Laboratory investigation of platelet function","volume":"21","author":"Storey","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.thromres.2008.03.008_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/09537100400020567","article-title":"Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA","volume":"16","author":"McDabe","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2008.03.008_bib33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1365-2141.1996.d01-1729.x","article-title":"The reduction of large von Willebrand factor multimers in plasma in essential thrombocythemia is related to the platelet count","volume":"93","author":"van Genderen","year":"1996","journal-title":"Br J Haematol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384808000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384808000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T17:06:01Z","timestamp":1557507961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384808000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0049384808000911"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2008.03.008","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}